MIRA Reports Positive 7-Day Dog Study Results for SKNY-1Obesity Treatment Candidate Designed to Preserve Lean Body Mass
MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling StudiesCompletion of 7-Day Toxicology and Pharmacokinetic Studies Advances Non-Opioid Pain Therapy and Obesity Candidate Development
